by | Oct 31, 2025 | Lupus Foundation of America
Top 3 Takeaways from the Webinar:Addressing sexual health is an important part of living well with lupus. Many people with lupus experience changes in libido, vaginal comfort or emotional well-being. Recognizing these as valid health issues is the first step toward...
by | Oct 29, 2025 | Lupus Foundation of America
This year the annual American College of Rheumatology (ACR) Convergence meeting took place in Chicago, IL from October 24 – 29, 2025. Each year the conference showcases the latest in cutting-edge lupus research and treatment. Bringing together scientists, clinicians,...
by | Oct 27, 2025 | Lupus Foundation of America
The Lupus Foundation of America (LFA) celebrated exceptional lupus researchers at the 20th Anniversary Evelyn V. Hess Reception. Karen Costenbader, MD, MPH, Brigham and Women’s Hospital, was honored with the 2025 Evelyn V. Hess Award, and Andrea Fava, MD, Johns...
by | Oct 26, 2025 | Lupus Foundation of America, News & Events
Today at the American College of Rheumatology (ACR) Annual Meeting, Convergence 2025, the ACR held a discussion of the new guidelines for the treatment and management of systemic lupus erythematosus (SLE), the most common form of lupus. These guidelines provide an...
by | Oct 21, 2025 | Lupus Foundation of America
The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in Chicago, IL, taking place October 24-29. The presented research will...
by | Oct 20, 2025 | Lupus Foundation of America
FDA approval of Gazyva expands therapeutic options for lupus careThe U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease....